InMed Pharma Advances Toward Clinical Trials with CRO Deal -- Cfn Media

InMed Pharma Advances Toward Clinical Trials with CRO Deal -- Cfn Media
InMed Pharma Advances Toward Clinical Trials with CRO Deal -- Cfn Media

CFN Media Group ("CannabisFN"), announces the publication of an article discussing InMed Pharmaceuticals Inc. (CNSX: IN) (OTCQB: IMLFF) and the progress it is making in advancing its lead clinical trial candidate.